- Home
- VVOS vs CLDI Comparison
VVOS vs CLDI Comparison
Compare VVOS & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VVOS
- CLDI
- Stock Information
- Founded
- VVOS 2016
- CLDI 2014
- Country
- VVOS United States
- CLDI United States
- Employees
- VVOS N/A
- CLDI N/A
- Industry
- VVOS Medical Specialities
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VVOS Health Care
- CLDI Health Care
- Exchange
- VVOS Nasdaq
- CLDI Nasdaq
- Market Cap
- VVOS 14.8M
- CLDI 12.0M
- IPO Year
- VVOS 2020
- CLDI N/A
- Fundamental
- Price
- VVOS $2.23
- CLDI $0.36
- Analyst Decision
- VVOS Strong Buy
- CLDI Strong Buy
- Analyst Count
- VVOS 2
- CLDI 1
- Target Price
- VVOS $6.10
- CLDI $10.00
- AVG Volume (30 Days)
- VVOS 133.6K
- CLDI 456.3K
- Earning Date
- VVOS 05-15-2025
- CLDI 05-14-2025
- Dividend Yield
- VVOS N/A
- CLDI N/A
- EPS Growth
- VVOS N/A
- CLDI N/A
- EPS
- VVOS N/A
- CLDI N/A
- Revenue
- VVOS $14,628,000.00
- CLDI N/A
- Revenue This Year
- VVOS $17.40
- CLDI N/A
- Revenue Next Year
- VVOS $10.78
- CLDI N/A
- P/E Ratio
- VVOS N/A
- CLDI N/A
- Revenue Growth
- VVOS 9.47
- CLDI N/A
- 52 Week Low
- VVOS $1.97
- CLDI $0.34
- 52 Week High
- VVOS $6.28
- CLDI $3.89
- Technical
- Relative Strength Index (RSI)
- VVOS 40.40
- CLDI 34.85
- Support Level
- VVOS $2.22
- CLDI $0.34
- Resistance Level
- VVOS $2.49
- CLDI $0.39
- Average True Range (ATR)
- VVOS 0.22
- CLDI 0.04
- MACD
- VVOS -0.01
- CLDI 0.00
- Stochastic Oscillator
- VVOS 43.86
- CLDI 15.45
About VVOS Vivos Therapeutics Inc.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.